Paranoid Schizophrenia versus Schizoaffective Disorder: Neuropsychological Aspects

被引:2
|
作者
Leposavic, Ljubica [1 ]
Leposavic, Ivana [2 ]
Saula-Marojevic, Biljana [2 ]
Gavrilovic, Predrag [3 ]
机构
[1] Univ Belgrade, Sch Med, Belgrade, Serbia
[2] Clin Ctr Serbia, Psychiat Clin, Belgrade 11000, Serbia
[3] Coll Sport & Hlth, Belgrade, Serbia
关键词
neuropsychology; schizoaffective disorder; paranoid schizophrenia; 1ST EPISODE SCHIZOPHRENIA; EXECUTIVE FUNCTION; PSYCHOSIS; THINKING;
D O I
10.2298/SARH1508391L
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Neuropsychological aspects of paranoid schizophrenia have still not been examined enough.These disorders are usually not studied separately, but are included in the studies about schizophrenic patients with positive symptoms. Despite the fact that schizophrenia represents a heterogeneous group of mental disorders, usually it is not separated from schizoaffective disorder in neuropsychological researches. Objective The essence of this research is to evaluate cognitive functioning of patients with paranoid schizophrenia and schizoaffective disorder by applying neuropsychological tests. Methods The research included 91 subjects, right handed, from 30 to 53 years old, who were classified into three groups: inpatients with paranoid schizophrenia in remission (n=31), inpatients with schizoaffective disorder in remission (n=30) and healthy subjects (n=30). Results Both groups of patients showed poorer achievements than healthy subjects in most of the applied tests. Patients with schizoaffective disorder showed global loss of intellectual efficiency, executive dysfunction and compromised visual construction organization. Patients with paranoid schizophrenia expressed partial loss of intellectual efficiency with verbal IQ and executive functions preserved. Conclusion In the remission phase, patients with paranoid schizophrenia expressed cognitive disorders in moderate degree, but when it comes to patients with schizoaffective disorder, more massive cognitive deficits were registered.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 50 条
  • [31] Spotlight on ziprasidone in schizophrenia and schizoaffective disorder
    Gunasekara, NS
    Spencer, CM
    Keating, GM
    [J]. CNS DRUGS, 2002, 16 (09) : 645 - 652
  • [32] SYSTEMATIZED DELUSIONS AND NEUROPSYCHOLOGICAL FUNCTION IN PARANOID AND NONPARANOID SCHIZOPHRENIA
    KREMEN, WS
    SEIDMAN, LJ
    GOLDSTEIN, JM
    FARAONE, SV
    TSUANG, MT
    [J]. SCHIZOPHRENIA RESEARCH, 1994, 12 (03) : 223 - 236
  • [33] The cost of relapse in schizophrenia and schizoaffective disorder
    Fitzgerald, Paul
    de Castella, Anthony
    Arya, Dinesh
    Simons, W. Robert
    Eggleston, Andrew
    Meere, Sharon
    Kulkarni, Jayashari
    [J]. AUSTRALASIAN PSYCHIATRY, 2009, 17 (04) : 265 - 272
  • [34] Schizoaffective disorder and schizophrenia: Clinical differences
    Romosan, F.
    Ienciu, L. M.
    Romosan, A. M.
    Romosan, R. S.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S831 - S831
  • [35] Absence: Schizophrenia, Schizoaffective Disorder, and Marriage
    Christin, Wendy Singleton
    [J]. SCHIZOPHRENIA BULLETIN, 2021, 47 (03) : 590 - 591
  • [36] Premorbid adjustment in schizophrenia and schizoaffective disorder
    Saracco-Alvarez, Ricardo
    Rodriguez-Verdugo, Soledad
    Garcia-Anaya, Maria
    Fresan, Ana
    [J]. PSYCHIATRY RESEARCH, 2009, 165 (03) : 234 - 240
  • [37] Contextual processing in schizophrenia and schizoaffective disorder
    Casas, B
    Deldin, PJ
    Maher, B
    Manschreck, T
    Kantrowitz-Rollins, C
    Redmond, D
    Rosato, M
    [J]. PSYCHOPHYSIOLOGY, 2000, 37 : S31 - S31
  • [38] Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder
    Nishan S. Gunasekara
    Caroline M. Spencer
    Gillian M. Keating
    [J]. CNS Drugs, 2002, 16 : 645 - 652
  • [39] Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    Kane, JM
    Carson, WH
    Saha, AR
    McQuade, RD
    Ingenito, GG
    Zimbroff, DL
    Ali, MW
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (09) : 763 - 771
  • [40] CLINICAL AND NEUROPSYCHOLOGICAL PREDICTORS OF GLOBAL FUNCTIONING IN PARANOID SCHIZOPHRENIA
    Garcia-Cabeza, I.
    Vicente, I.
    Sanchez Ayuso, M. J.
    Laorden, A.
    De Portugal, E.
    [J]. EUROPEAN PSYCHIATRY, 2013, 28